• $2,521.00
    Market Cap
  • 0.00%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
06/30/2023
06/30/2022
06/30/2021
Income Statement
Total Operating Revenue
114,596
+342.95%
25,871
N/A
N/A
N/A
Cost of Revenue
26,897
+863.36%
2,792
N/A
N/A
N/A
Gross Profit
87,699
+279.99%
23,079
N/A
0
N/A
Sales and Marketing Expense
31,405
-71.84%
111,527
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
60,091
+66.82%
36,021
+229.53%
10,931
N/A
Total Operating Expenses
1.0M
-47.24%
1.9M
+3,095.79%
60,165
N/A
Operating Profit
-926,658
-51.22%
-1.9M
+3,057.43%
-60,165
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-234,219
+55.78%
-150,351
N/A
N/A
N/A
Interest Income and Expense and Net
-234,219
+55.78%
-150,351
N/A
0
N/A
Total Nonoperating Income and Expense
-3.8M
+378.13%
-800,839
N/A
N/A
N/A
Income before Taxes
-4.8M
+76.10%
-2.7M
-14.77%
-3.2M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-4.8M
+76.10%
-2.7M
-14.08%
-3.1M
N/A
Net Income from Continuing Operations Applicable to Common
-4.8M
+76.10%
-2.7M
-14.77%
-3.2M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
-0.14
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
-0.14
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
23.0M
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
23.0M
N/A
Balance Sheet
Cash and Cash Equivalents
0
-100.00%
295,914
+2,063.59%
13,677
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
-100.00%
295,914
+2,063.59%
13,677
N/A
Total Current Assets
0
-100.00%
301,044
+2,101.10%
13,677
N/A
Accumulated Depreciation
38,202
-3.78%
39,701
+389.05%
8,118
N/A
Property and Plant and Equipment and Net
91,404
-41.26%
155,599
+42.81%
108,954
N/A
Total Long-Term Assets
91,404
+1,445.81%
5,913
-94.57%
108,954
N/A
Total Assets
91,404
-80.24%
462,556
+235.47%
137,881
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
22,729
-46.06%
42,135
-87.14%
327,562
N/A
Total Current Liabilities
4.7M
+162.57%
1.8M
+325.52%
420,611
N/A
Total Long-Term Debt
1.8M
+97.44%
905,111
N/A
N/A
N/A
Total Long-Term Liabilities
2.5M
+273.38%
662,982
N/A
N/A
N/A
Total Liabilities
4.7M
+162.57%
1.8M
+325.52%
420,611
N/A
Retained Earnings
-11.0M
+76.76%
-6.2M
+77.27%
-3.5M
N/A
Total Stockholders Equity
-4.6M
+247.20%
-1.3M
+369.43%
-282,730
N/A
Total Shares Outstanding
1.4B
+546.22%
220.0M
+682.95%
28.1M
N/A
Cash Flow
Cash from Operating Activities
-763,535
+7.22%
-712,145
-1,174.17%
66,297
N/A
Capital Expenditures
82,309
+8.86%
75,612
+243.69%
22,000
N/A
Cash from Investing Activities
-128,559
+70.02%
-75,612
-31.33%
-110,117
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
596,180
-44.28%
1.1M
+1,760.96%
57,497
N/A
Financials Ratio
Gross Margin
76.53%
-14.21%
89.21%
N/A
N/A
N/A
Operating Margin
-808.63%
-88.99%
-7,342.85%
N/A
N/A
N/A
Return on Assets
-1,716.99%
+90.88%
-899.51%
+41.11%
-637.48%
N/A
Return on Equity
160.25%
-52.23%
335.48%
-88.14%
2,827.58%
N/A
Revenue Growth
342.95%
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.00
-100.00%
0.17
+417.54%
0.03
N/A
Cash Ratio
0.00
-100.00%
0.17
+408.62%
0.03
N/A
Debt-to-Equity Ratio
-0.39
-44.98%
-0.71
N/A
N/A
N/A
Debt-to-Assets Ratio
19.80
+866.84%
2.05
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow